Core Viewpoint - The company has decided to postpone the completion dates of its fundraising investment projects due to actual project conditions, while maintaining the investment amounts and purposes unchanged [4][6]. Group 1: Fundraising Overview - The company raised a total of 300,000 million yuan through the issuance of 30 million convertible bonds, with a net amount of 2,963,773,962.16 yuan after deducting issuance costs [1]. - The funds are allocated for two main projects: the production of 250,000 tons of ultra-pure alcohol-based fine chemicals and 225,000 tons of high-performance resin raw materials, along with 80,000 million yuan for working capital [2]. Group 2: Project Status and Delays - The project for producing 250,000 tons of ultra-pure alcohol-based fine chemicals is expected to be completed by June 2026, while the high-performance resin raw materials project is also postponed to June 2026 [2][5]. - The delays are attributed to impacts from public health events and regional control measures, which have hindered construction progress [4]. Group 3: Decision-Making and Compliance - The company’s board and supervisory committee approved the postponement of the investment projects on June 27, 2025, ensuring compliance with relevant regulations [6]. - The sponsor institution has confirmed that the postponement will not adversely affect the company's operations or shareholder interests, and the necessary approval procedures have been followed [6].

Core Viewpoint - The company has decided to postpone the completion date of a specific investment project due to prudent considerations and the current status of fundraising and project progress [1] Group 1 - The company held its 27th meeting of the third board of directors and the 23rd meeting of the third supervisory board on June 27, 2025 [1] - The company approved the proposal to delay the "Guizhou Renhuai Bosheng Intelligent Paper Wine Box Production Base Construction Project" [1] - The new expected completion date for the project has been adjusted from June 2025 to December 2025 [1]

Fundraising Overview - The company has been approved to publicly issue 23,508,800 shares at a price of RMB 50.31 per share, raising a total of RMB 1,182,727,728, with excess funds amounting to RMB 693,369,702.40 after deducting issuance costs [1][2]. Fund Utilization - The company has outlined its fundraising projects and usage plans, with specific investment amounts and progress reported as of May 31, 2025 [2][3]. Project Delay Reasons - The company has decided to postpone certain fundraising projects due to market conditions and overall project progress, ensuring that the project implementation entities, investment purposes, and scales remain unchanged [3][4]. Impact of Project Delay - The delay in fundraising projects is a cautious decision based on actual progress, and it does not affect the company's current operations significantly. The investment total, project content, and implementation entities remain unchanged, ensuring no harm to shareholder interests [4][5]. Approval Procedures - The company's board of directors and supervisory board have approved the project delays, confirming that necessary procedures were followed and that the delays do not alter the intended use of funds [5]. Sponsor's Verification - The sponsor has verified that the project delays have been approved by the board and supervisory board, and there are no changes to the intended use of funds, complying with relevant regulations [5].

Core Viewpoint - The company has decided to terminate part of its fundraising projects and delay others, based on a careful assessment of the current market conditions and project progress, ensuring that these decisions align with the long-term interests of the company and its shareholders [1][10]. Fundraising Overview - The company raised a net amount of RMB 1,002,572,682.71 through its initial public offering, verified by an accounting firm [1]. - The company has established a management system for the use of raised funds, ensuring that funds are stored in dedicated accounts and used strictly for their intended purposes [2]. Termination of Fundraising Projects - The project "Zihang Medical Device Component Intelligent Manufacturing and Expansion Project" will be terminated, with the total investment amount reduced from RMB 282.84 million to RMB 143.47 million, and the fundraising investment amount decreased from RMB 282.84 million to RMB 135.77 million [3]. - The termination is influenced by changes in market demand and increased competition, leading to a reassessment of the project's viability [6][7]. Reasons for Project Termination - The implementation of centralized procurement policies has created volatility in market demand, affecting the sales cycle and capacity planning for the project [6]. - The existing production capacity is deemed sufficient to meet current demand, and further investment could lead to idle capacity risks [7]. Impact of Project Termination - The termination is expected to enhance the efficiency of fundraising usage and will not adversely affect the company's normal operations or shareholder interests [8]. - The remaining funds from the terminated project will be retained in dedicated accounts for future investment opportunities [8]. Delay of Fundraising Projects - The "Weike Medical Minimally Invasive Surgical New Product Project" will be delayed, with the expected completion date pushed from June 30, 2025, to December 31, 2027 [9]. - The delay is attributed to changes in market conditions and the need for further product development to meet diverse customer needs [9]. Reasons for Project Delay - The company is adapting to market changes and enhancing product features through increased R&D investment, which has necessitated a phased approach to project implementation [9]. - The execution of procurement policies has affected the expected market release timeline for the company's products [9]. Impact of Project Delay - The delay is a strategic decision that does not involve changes to the project’s implementation structure or total investment, ensuring that it aligns with the company's long-term development goals [9][10].

Core Viewpoint - The company, Hengguang Co., Ltd., is experiencing a slowdown in the construction progress of its fundraising projects due to the low industry prosperity cycle, leading to a delay in the completion of its 55,000-ton fine chemical new materials production line project from June 30, 2025, to December 31, 2026 [1] Group 1: Project Updates - The 55,000-ton fine chemical new materials production line project includes two sub-projects: a 5,000-ton 2-ethyl anthraquinone production line and a 50,000-ton sodium chlorite production line [2] - The company has completed the technical optimization of the 5,000-ton 2-ethyl anthraquinone production line, but achieving full production will take additional time [2] - Due to the complex market environment and macroeconomic conditions, the company has decided to suspend the investment in the 50,000-ton sodium chlorite production line [2] Group 2: Financial Performance - Since its IPO, Hengguang Co., Ltd. has invested a total of 3.43 billion yuan in its fundraising projects, with an overall investment progress of 60.57% as of May 2025 [1] - The company reported revenues of 933 million yuan, 1.08 billion yuan, 936 million yuan, and 1.235 billion yuan from 2021 to 2024, with net profits of 242 million yuan, 202 million yuan, -37.55 million yuan, and -60.93 million yuan respectively [2] - The company has incurred losses for two consecutive years in 2023 and 2024, totaling approximately 98.48 million yuan [2] Group 3: Reasons for Losses - The company attributes its losses in 2024 to four main factors: low product gross margins, high fixed costs due to increased production capacity, rising energy prices post-market reform, and asset impairment provisions [3] - The gross margin for the company's main business was 8.05% in 2024, a decrease of 1.58 percentage points year-on-year [3] - The gross margins for the chlor-alkali and sulfur chemical product chains were 9.69% and 3.02%, reflecting changes of 3.13 and -12.93 percentage points respectively [3]

Core Viewpoint - The company, Hunan Hengguang Technology Co., Ltd., has decided to postpone certain fundraising projects due to actual progress and market conditions, ensuring that the adjustments do not affect the overall investment direction or shareholder interests [7][12]. Fundraising Overview - The company raised a total of RMB 605.41 million through its initial public offering, with a net amount of RMB 540.81 million after deducting related issuance costs [1][2]. Fund Usage Status - As of May 31, 2025, the company has invested RMB 343.30 million, which is 60.57% of the total planned investment of RMB 566.81 million for the first phase of the fine chemical new materials production base [4]. Project Postponement Details - The company has postponed the completion date of the "5.5 million tons fine chemical new materials production line construction project" from June 30, 2025, to December 31, 2026, due to technical optimizations and market uncertainties [9][11]. Reasons for Postponement - The postponement is attributed to the need for technical adjustments in the "5,000 tons 2-ethyl anthraquinone production line" and the decision to delay investment in the "50,000 tons sodium chlorite production line" to protect shareholder interests amid a complex market environment [9][10]. Impact of Postponement - The postponement will not change the project content, implementation subject, or total investment amount, and is expected to have no adverse effects on the company's current operations [10][12]. Approval Process - The postponement was approved through necessary procedures by the independent directors, board of directors, and supervisory board, confirming compliance with relevant regulations and ensuring no harm to shareholder interests [10][11][12].

证券代码：301252 证券简称：同星科技 公告编号：2025-020 浙江同星科技股份有限公司 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 浙江同星科技股份有限公司(以下简称"公司")第三届监事会第十五次会议于 年 6 月 9 日通过书面文件、电话等方式送达给全体监事。本次会议由公司监事会主 席吴兆庆先生主持，应出席监事 3 人，实际出席监事 3 人。本次会议的召集、召开 和表决程序符合法律、法规、规范性文件和《公司章程》的有关规定。 二、监事会会议审议情况 （一）审议通过《关于部分募投项目结项并将节余募集资金永久补充流动资金 的议案》 经审议，监事会认为：本次公司部分募投项目结项并将节余募集资金永久补充流 动资金，是根据公司募投项目实际进展情况和公司自身经营情况做出的合理安排，有 利于提高资金使用效率，降低财务成本，审议程序符合相关法律法规、规范性文件及 《公司章程》《募集资金管理制度》等相关规定，不存在变相改变募集资金用途的行 为，不存在损害公司及全体股东利益的情形。因此，监事会同意本次公司部分募投项 目结项并将节余募集资金永 ...

Group 1 - The company held its 11th meeting of the 5th Supervisory Board on June 20, 2025, with all three supervisors present, including two via remote voting [1] - The Supervisory Board approved the proposal to postpone certain fundraising projects with a unanimous vote, stating that the postponement does not change the purpose or direction of the raised funds and will not materially affect the company's operations [1][2] - The board also reviewed a proposal to amend the remuneration management measures for directors, supervisors, and senior management, with all supervisors abstaining from the vote, which will be submitted to the shareholders' meeting for approval [2][3] Group 2 - The Supervisory Board approved adjustments to the repurchase price of the 2024 restricted stock incentive plan with a majority vote, confirming that the adjustments comply with relevant regulations and do not harm shareholder interests [2][3]

Group 1 - The company has experienced rapid development in its Jiangyou Industrial Park in 2023, particularly in the photovoltaic new energy sector, leading to an increase in the number of grassroots management personnel [1] - In 2024, the company streamlined some grassroots management positions while retaining core middle management, resulting in an overall increase in average salary levels compared to 2023 [1] - The average salary level of the company differs significantly from that of its peers, with companies like Jinbo Co. and Oujing Technology having lower labor costs due to their locations [1] Group 2 - The company announced a postponement of its fundraising investment project, which was deemed a prudent decision based on the actual implementation status of the project [5][14] - The project in question, the automation and intelligent upgrade of the quartz crucible production line, will now reach its intended usable state by December 31, 2026, due to delays in the installation of supporting equipment [12] - The postponement will not adversely affect the company's existing production lines or overall operations, and the project remains compliant with relevant regulations [14][15]

Core Viewpoint - The company held its third meeting of the ninth supervisory board, where several key resolutions were passed, including amendments to the company's articles of association and adjustments to the employee stock ownership plan [1][2]. Group 1: Resolutions Passed - The supervisory board approved the proposal to amend the company's articles of association with a vote of 3 in favor, 0 against, and 0 abstentions [1]. - The proposal regarding adjustments to the fourth employee stock ownership plan was discussed but could not be resolved due to insufficient non-related supervisors present for a quorum [2]. - The supervisory board approved the proposal to extend the fundraising project with a unanimous vote of 3 in favor, 0 against, and 0 abstentions [2]. Group 2: Meeting Details - The meeting was convened on June 18, 2025, and was chaired by Mr. Zhang Jisong, the chairman of the supervisory board [1]. - The meeting complied with the requirements of the Company Law of the People's Republic of China and the company's articles of association [1].